Estimates of US influenza-associated deaths made using four different methods

William W Thompson, Eric Weintraub, Praveen Dhankhar, Po-Yung Cheng, Lynnette Brammer, Martin I Meltzer, Joseph S Bresee, David K Shay, William W Thompson, Eric Weintraub, Praveen Dhankhar, Po-Yung Cheng, Lynnette Brammer, Martin I Meltzer, Joseph S Bresee, David K Shay

Abstract

Background: A wide range of methods have been used for estimating influenza-associated deaths in temperate countries. Direct comparisons of estimates produced by using different models with US mortality data have not been published.

Objective: Compare estimates of US influenza-associated deaths made by using four models and summarize strengths and weaknesses of each model.

Methods: US mortality data from the 1972-1973 through 2002-2003 respiratory seasons and World Health Organization influenza surveillance data were used to estimate influenza-associated respiratory and circulatory deaths. Four models were used: (i) rate-difference (using peri-season or summer-season baselines), (ii) Serfling least squares cyclical regression, (iii) Serfling-Poisson regression, (iv) and autoregressive integrated moving average models.

Results: Annual estimates of influenza-associated deaths made using each model were similar and positively correlated, except for estimates from the summer-season rate-difference model, which were consistently higher. From the 1976/1977 through the 2002/2003 seasons the, the Poisson regression models estimated that an annual average of 25,470 [95% confidence interval (CI) 19,781-31,159] influenza-associated respiratory and circulatory deaths [9.9 deaths per 100,000 (95% CI 7.9-11.9)], while peri-season rate-difference models using a 15% threshold estimated an annual average of 22,454 (95% CI 16,189-28,719) deaths [8.6 deaths per 100,000 (95% CI 6.4-10.9)].

Conclusions: Estimates of influenza-associated mortality were of similar magnitude. Poisson regression models permit the estimation of deaths associated with influenza A and B, but require robust viral surveillance data. By contrast, simple peri-season rate-difference models may prove useful for estimating mortality in countries with sparse viral surveillance data or complex influenza seasonality.

References

    1. Serfling RE. Methods for current statistical analysis of excess pneumonia‐influenza deaths. Public Health Rep 1963; 78:494–505.
    1. Lui KJ, Kendal AP. Impact of influenza epidemics on mortality in the United States from October 1972 to May 1985. Am J Public Health 1987; 77:712–716.
    1. Simonsen L, Fukuda K, Schonberger LB, Cox NJ. The impact of influenza epidemics on hospitalizations. J Infect Dis 2000; 181:831–837.
    1. Thompson WW, Shay DK, Weintraub E et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003; 289:179–186.
    1. Meltzer MI, Cox NJ, Fukuda K. The economic impact of pandemic influenza in the United States: priorities for intervention. Emerg Infect Dis 1999; 5:659–671.
    1. Nichol KL. The efficacy, effectiveness and cost‐effectiveness of inactivated influenza virus vaccines. Vaccine 2003; 21:1769–1775.
    1. Bridges CB, Harper SA, Fukuda K, Uyeki TM, Cox NJ, Singleton JA. Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2003; 52(RR‐8):1–34.
    1. Thompson WW, Shay DK, Weintraub E et al. Influenza‐associated hospitalizations in the United States. JAMA 2004; 292:1333–1340.
    1. Simonsen L, Clarke MJ, Schonberger LB, Arden NH, Cox NJ, Fukuda K. Pandemic versus epidemic influenza mortality: a pattern of changing age distribution. J Infect Dis 1998; 178:53–60.
    1. Nichol KL, Baken L, Nelson A. Relation between influenza vaccination and outpatient visits, hospitalization, and mortality in elderly persons with chronic lung disease. Ann Intern Med 1999; 130:397–403.
    1. Nichol KL, Wuorenma J, Von Sternberg T. Benefits of influenza vaccination for low‐, intermediate‐, and high‐risk senior citizens. Arch Intern Med 1998; 158:1769–1776.
    1. Noble GR. Epidemiogical and clinical aspects of influenza; in Bears AS. (ed): Basic and Applied Influenza Research. Boca Raton, FL: CRC Press, 1982, 11–50.
    1. Choi K, Thacker SB. Mortality during influenza epidemics in the United States, 1967–1978. Am J Public Health 1982; 72:1280–1283.
    1. Barker WH, Mullooly JP. Impact of epidemic type A influenza in a defined adult population. Am J Epidemiol 1980; 112:798–811.
    1. Barker WH, Mullooly JP. Pneumonia and influenza deaths during epidemics: implications for prevention. Arch Intern Med 1982; 142:85–89.
    1. Izurieta HS, Thompson WW, Kramarz P et al. Influenza and the rates of hospitalization for respiratory disease among infants and young children. N Engl J Med 2000; 342:232–239.
    1. O’Brien MA, Uyeki TM, Shay DK, et al. Incidence of outpatient visits and hospitalizations related to influenza in infants and young children. Pediatrics 2004; 113(3 Pt 1):585–593.
    1. Simonsen L, Clarke MJ, Williamson GD, Stroup DF, Arden NH, Schonberger LB. The impact of influenza epidemics on mortality: introducing a severity index. Am J Public Health 1997; 87:1944–1950.
    1. Neuzil KM, Maynard C, Griffin MR, Heagerty P. Winter respiratory viruses and health care use: a population‐based study in the northwest United States. Clin Infect Dis 2003; 37:201–207.
    1. Choi K, Thacker SB. An evaluation of influenza mortality surveillance, 1962–1979 I. Time series forecasts of expected pneumonia and influenza deaths. Am J Epidemiol 1981; 113:215–226.
    1. Stroup DF, Thacker SB, Herndon JL. Application of multiple time series analysis to the estimation of pneumonia and influenza mortality by age 1962–1983. Stat Med 1988; 7:1045–1059.
    1. Brammer TL, Izurieta HS, Fukuda K et al. Surveillance for influenza–United States, 1994–95, 1995–96, and 1996–97 seasons. Morb Mortal Wkly Rep CDC Surveill Summ 2000; 49:13–28.
    1. Vital Statistics Mortality Data, Multiple Cause Detail, 1972–2004 . Public Use Data Tapes Contents and Documentation Package. Hyattsville, MD: National Center for Health Statistics, 2004.
    1. World Health Organization . Manual of the International Statistical Classification of Diseases, Injuries, and Causes of Death, based on recommendations of the Ninth Revision Conference, 1975. Geneva: World Health Organization, 1977.
    1. Mullooly JP, Bridges CB, Thompson WW et al. Influenza‐ and RSV‐associated hospitalizations among adults. Vaccine 2007; 25:846–855.
    1. Simonsen L, Clarke MJ, Stroup DF, Williamson GD, Arden NH, Cox NJ. A method for timely assessment of influenza‐associated mortality in the United States. Epidemiology 1997; 8:390–395.
    1. Thompson WW, Weintraub E, Shay DK, Brammer L, Cox NJ, Fukuda K. Influenza‐attributable hospitalizations in the United States; in Osterhaus A, Cox NJ. (eds): Options for the Control of Influenza V. Hampson: Elsevier Science, 2003.
    1. Thompson WW, Shay DK, Weintraub E, Brammer L, Cox NJ, Fukuda K. Influenza‐attributable deaths among the elderly in the United States; in Osterhaus A, Cox NJ. (eds): Options for the Control of Influenza V. Hampson: Elsevier Science, 2003.
    1. US Bureau of the Census . Intercensal Estimates of the Population by Age, Sex, and Race: 1970‐2000. Washington DC: US Bureau of the Census, 2005.
    1. Thompson WW, Shay DK, Weintraub E et al. In Reply to Letters. JAMA 2003; 289:2500–2502.
    1. Choi K, Thacker SB. From the centers for disease control. Improved accuracy and specificity of forecasting deaths attributed to pneumonia and influenza. J Infect Dis 1981; 144:606–608.
    1. Choi K, Thacker SB. An evaluation of influenza mortality surveillance, 1962–1979. II. Percentage of pneumonia and influenza deaths as an indicator of influenza activity. Am J Epidemiol 1981; 113:227–235.
    1. Box G, Jenkins GM. Time‐Series Analysis; Forecasting and Control. San Francisco: Holden‐Day, 1970.
    1. Meltzer MI, Neuzil KM, Griffin MR, Fukuda K. An economic analysis of annual influenza vaccination of children. Vaccine 2005; 23:1004–1014.
    1. Prosser LA, Bridges CB, Uyeki TM et al. Health benefits, risks, and cost‐effectiveness of influenza vaccination of children. Emerg Infect Dis 2006; 12:1548–1558.

Source: PubMed

赞助者和合作者

医疗条件

药物干预

3
订阅